Cargando…
Subclinical granulomas in benign skin lesions heralding the onset of BRAF and MEK inhibitor–associated granulomatous dermatitis in a patient with metastatic melanoma
Autores principales: | Korman, Abraham M., Nisar, Mahrukh S., Somach, Stephen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113653/ https://www.ncbi.nlm.nih.gov/pubmed/30167445 http://dx.doi.org/10.1016/j.jdcr.2018.05.011 |
Ejemplares similares
-
Interstitial Granulomatous Dermatitis with Granuloma Annulare-Like Pattern Following Liposuction
por: Agarwal, Indu, et al.
Publicado: (2017) -
Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case report
por: Maanaoui, Mehdi, et al.
Publicado: (2017) -
Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma
por: Smalley, Keiran SM, et al.
Publicado: (2015) -
Generalized granuloma annulare heralding relapse of non-Hodgkin lymphoma
por: King, Sarah A., et al.
Publicado: (2020) -
Integrating BRAF/MEK inhibitors into combination therapy for melanoma
por: Smalley, K S M, et al.
Publicado: (2009)